| 2013 | 10 | “Practical application of clinical iPS cell production technology” adopted for Program for Creating STart-ups from Advanced Research and Technology (START)
|
| 2014 | 12 | TOKIWA-Bio Inc. was established.
|
| 2015 | 3 | Recognized by AIST as AIST start-ups and established headquarters and research facility in AIST Tsukuba Central Office
|
| 2016 | 11 | Head office moved to Tsukuba Center Inc.(TCI)
|
| 2017 | 11 | TOKIWA-Bio Inc. raised 330 million yen through third-party allotment.
|
| 2018 | 10 | TOKIWA-Bio Inc. was adopted by Japan Agency for Medical Research and Development(AMED) Project for “Genetic and Cellular Therapeutic Research and Development”
|
| 2019 | 8 | TOKIWA-Bio Inc. was adopted by Japan Agency for Medical Research and Development(AMED) Project for “Basic Technology Development for Industrialization of Regenerative Medicine and Gene Therapy(regenerative medicine seeds development acceleration support)”
|